Cytokine responses in porcine respiratory coronavirus-infected pigs treated with corticosteroids as a model for severe acute respiratory syndrome

Journal of Virology

Volumn 82, Issue 9, 2008, Pages 4420-4428

  Zhang, Xinsheng ^a   Alekseev, Konstantin ^a   Jung, Kwonil ^a   Vlasova, Anastasia ^a   Hadya, Nagesh ^a   Saif, Linda J ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 6; PHOSPHATE BUFFERED SALINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONAVIRUS; CYTOKINE RELEASE; DRUG MECHANISM; LUNG LAVAGE; LUNG LESION; NONHUMAN; PRIORITY JOURNAL; SEVERE ACUTE RESPIRATORY SYNDROME; SWINE; TH1 CELL; TH2 CELL;

ADRENAL CORTEX HORMONES; ANIMALS; CORONAVIRUS INFECTIONS; CYTOKINES; DEXAMETHASONE; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, CELLULAR; IMMUNOSUPPRESSION; PORCINE RESPIRATORY CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SWINE;

PORCINE RESPIRATORY CORONAVIRUS; SUIDAE;

EID: 42449164671     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02190-07     Document Type: Article

References (66)

1. Ahn, K., C. Chae, and C. H. Kweon. 1997. Immunohistochemical identification of porcine respiratory coronavirus antigen in the lung of conventional pigs. Vet. Pathol. 34:167-169.
2. Amano, Y., S. W. Lee, and A. C. Allison. 1993. Inhibition by glucocorticoids of the formation of interleukin-1 alpha, interleukin-1 beta, and interleukin-6: mediation by decreased mRNA stability. Mol. Pharmacol. 43:176-182.
3. Auyeung, T. W., J. S. Lee, W. K. Lai, C. H. Choi, H. K. Lee, J. S. Lee, P. C. Li, K. H. Lok, Y. Y. Ng, W. M. Wong, and Y. M. Yeung. 2005. The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study. J. Infect. 51:98-102.
4. Azevedo, M. S., L. Yuan, S. Pouly, A. M. Gonzales, K. I. Jeong, T. V. Nguyen, and L. J. Saif. 2006. Cytokine responses in gnotobiotic pigs after infection with virulent or attenuated human rotavirus. J. Virol. 80:372-382.
5. Baudoux, P., L. Besnardeau, C. Carrat, P. Rottier, B. Charley, and H. Laude. 1998. Interferon alpha inducing property of coronavirus particles and pseudoparticles. Adv. Exp. Med. Biol. 440:377-386.
6. Baudoux, P., C. Carrat, L. Besnardeau, B. Charley, and H. Laude. 1998. Coronavirus pseudoparticles formed with recombinant M and E proteins induce alpha interferon synthesis by leukocytes. J. Virol. 72:8636-8643.
7. Blotta, M. H., R. H. DeKruyff, and D. T. Umetsu. 1997. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. J. Immunol. 158:5589-5595.
8. Boersma, W. J., R. J. Zwart, J. Sinkora, Z. Rehakova, K. Haverson, and A. T. Bianchi. 2001. Summary of workshop findings for porcine B-cell markers. Vet. Immunol. Immunopathol. 80:63-78.
9. Byron, K. A., G. Varigos, and A. Wootton. 1992. Hydrocortisone inhibition of human interleukin-4. Immunology 77:624-626.
10. Callebaut, P., I. Correa, M. Pensaert, G. Jimenez, and L. Enjuanes. 1988. Antigenic differentiation between transmissible gastroenteritis virus of swine and a related porcine respiratory Coronavirus. J. Gen. Virol. 69:1725-1730.
11. Cameron, M. J., L. Ran, L. Xu, A. Danesh, J. F. Bermejo-Martin, C. M. Cameron, M. P. Muller, W. L. Gold, S. E. Richardson, S. M. Poutanen, B. M. Willey, M. E. DeVries, Y. Fang, C. Seneviratne, S. E. Bosinger, D. Persad, P. Wilkinson, L. D. Greller, R. Somogyi, A. Humar, S. Keshayjee, M. Louie, M. B. Loeb, J. Brunton, A. J. McGeer, Canadian SARS Research Network, and D. J. Kelvin. 2007. Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J. Virol. 81:8692-8706.
12. Chan, H. L., S. K. Tsui, and J. J. Sung. 2003. Coronavirus in severe acute respiratory syndrome (SARS). Trends Mol. Med. 9:323-325.
13. Chen, R. C., X. P. Tang, S. Y. Tan, B. L. Liang, Z. Y. Wan, J. Q. Fang, and N. Zhong. 2006. Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience. Chest 129:1441-1452.
14. Chien, J. Y., P. R. Hsueh, W. C. Cheng, C. J. Yu, and P. C. Yang. 2006. Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome. Respirology 11:715-722.
15. Cox, E., J. Hooyberghs, and M. B. Pensaert. 1990. Sites of replication of a porcine respiratory Coronavirus related to transmissible gastroenteritis virus. Res. Vet. Sci. 48:165-169.
16. Cox, E., M. Pensaert, J. Hooyberghs, and K. Van Deun. 1990. Sites of replication of a porcine respiratory Coronavirus in 5-week-old pigs with or without maternal antibodies. Adv. Exp. Med. Biol. 276:429-433.
17. Cyranoski, D. 2003. Critics slam treatment for SARS as ineffective and perhaps dangerous. Nature 423:4.
18. DeKruyff, R. H., Y. Fang, and D. T. Umetsu. 1998. Corticosteroids enhance the capacity of macrophages to induce Th2 cytokine synthesis in CD4+ lymphocytes by inhibiting IL-12 production. J. Immunol. 160:2231-2237.
19. Drosten, C., S. Gunther, W. Preiser, S. van der Werf, H. R. Brodt, S. Becker, H. Rabenau, M. Panning, L. Kolesnikova, R. A. Fouchier, A. Berger, A. M. Burguiere, J. Cinatl, M. Kickmann, N. Escriou, K. Grywna, S. Kramme, J. C. Manuguerra, S. Muller, V. Rickerts, M. Sturmer, S. Vieth, H. D. Klenk, A. D. Osterhaus, H. Schmitz, and H. W. Doerr. 2003. Identification of a novel Coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348:1967-1976.
20. Gessani, S., S. McCandless, and C. Baglioni. 1988. The glucocorticoid dexamethasone inhibits synthesis of interferon by decreasing the level of its mRNA. J. Biol. Chem. 263:7454-7457.
21. Hampton, T. 2005. Bats may be SARS reservoir. JAMA 294:2291.
22. Hill, H., J. Biwer, R. Woods, and R. Wesley. 1990. Porcine respiratory Coronavirus isolated from two US swine herds. Proc. Am. Assoc. of Swine Practitioners 21:333-335.
23. Jabrane, A., C. Girard, and Y. Elazhary. 1994. Pathogenicity of porcine respiratory coronavirus isolated in Quebec. Can. Vet. J. 35:86-92.
24. Jiang, Y., J. Xu, C. Zhou, Z. Wu, S. Zhong, J. Liu, W. Luo, T. Chen, Q. Qin, and P. Deng. 2005. Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. Am. J. Respir. Crit. Care Med. 171:850-857.
25. Jung, K., K. P. Alekseev, X. Zhang, D.-S. Cheon, A. N. Vlasova, and L. J. Saif. 2007. Altered pathogenesis of porcine respiratory coronavirus in pigs due to immunosuppressive effects of dexamethasone: implications for corticosteroid use in treatment of severe acute respiratory syndrome coronavirus. J. Virol. 81:13681-13693.
26. Kunicka, J. E., M. A. Talle, G. H. Denhardt, M. Brown, L. A. Prince, and G. Goldstein. 1993. Immunosuppression by glucocorticoids: inhibition of production of multiple lymphokines by in vivo administration of dexamethasone. Cell. Immunol. 149:39-49.
27. Lau, A. C., L. K. So, F. P. Miu, R. W. Yung, E. Poon, T. M. Cheung, and L. Y. Yam. 2004. Outcome of coronavirus-associated severe acute respiratory syndrome using a standard treatment protocol. Respirology 9:173-183.
28. Levy, D. E., I. Marie, and A. Prakash. 2003. Ringing the interferon alarm: differential regulation of gene expression at the interface between innate and adaptive immunity. Curr. Opin. Immunol. 15:52-58.
29. Li, W., Z. Shi, M. Yu, W. Ren, C. Smith, J. H. Epstein, H. Wang, G. Crameri, Z. Hu, H. Zhang, J. Zhang, J. McEachern, H. Field, P. Daszak, B. T. Eaton, S. Zhang, and L. F. Wang. 2005. Bats are natural reservoirs of SARS-like coronaviruses. Science 310:676-679.
30. Li, X. W., R. M. Jiang, and J. Z. Guo. 2003. Glucocorticoid in the treatment of severe acute respiratory syndrome patients: a preliminary report. Zhonghua Neike Zazhi 42:378-381. (In Chinese.)
31. Meng, Q. H., P. L. Dong, Y. B. Guo, K. Zhang, L. C. Liang, W. Hou, and J. L. Dong. 2003. Use of glucocorticoid in treatment of severe acute respiratory syndrome cases. Zhonghua Yufang Yixue Zazhi 37:233-235. (In Chinese.)
32. Min, D. I., and A. P. Monaco. 1991. Complications associated with immunosuppressive therapy and their management. Pharmacotherapy 11:119S-125S.
33. Mogensen, T. H., and S. R. Paludan. 2001. Molecular pathways in virus-induced cytokine production. Microbiol. Mol. Biol Rev. 65:131-150.
34. Nicholls, J. M., L. L. Poon, K. C. Lee, W. F. Ng, S. T. Lai, C. Y. Leung, C. M. Chu, P. K. Hui, K. L. Mak, W. Lim, K. W. Yan, K. H. Chan, N. C. Tsang, Y. Guan, K. Y. Yuen, and J. S. Peiris. 2003. Lung pathology of fatal severe acute respiratory syndrome. Lancet 361:1773-1778.
35. Nie, Q. H., X. D. Luo, and W. L. Hui. 2003. Advances in clinical diagnosis and treatment of severe acute respiratory syndrome. World J. Gastroenterol. 9:1139-1143.
36. Normile, D. 2005. Virology. Researchers tie deadly SARS virus to bats. Science 309:2154-2155.
37. Paludan, S. R. 1998. Interleukin-4 and interferon-gamma: the quintessence of a mutual antagonistic relationship. Scand. J. Immunol. 48:459-468.
38. Peiris, J. S., C. M. Chu, V. C. Cheng, K. S. Chan, I. F. Hung, L. L. Poon, K. I. Law, B. S. Tang, T. Y. Hon, C. S. Chan, K. H. Chan, J. S. Ng, B. J. Zheng, W. L. Ng, R. W. Lai, Y. Guan, and K. Y. Yuen. 2003. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361:1767-1772.
39. Perlman, S., and A. A. Dandekar. 2005. Immunopathogenesis of coronavirus infections: implications for SARS. Nat. Rev. Immunol. 5:917-927.
40. Prakash, A., E. Smith, C. K. Lee, and D. E. Levy. 2005. Tissue-specific positive feedback requirements for production of type I interferon following virus infection. J. Biol. Chem. 280:18651-18657.
41. Robinson, J. P., Z. Darzynkiewicz, P. N. Dean, A. R. Hibbs, A. Orfao, P. S. Rabinovitch, and L. L. Wheeless. 1997. Current protocols in cytometry, vol I, suppl. 24. John Wiley & Sons, Inc., New York, NY.
42. Rota, P. A., M. S. Oberste, S. S. Monroe, W. A. Nix, R. Campagnoli, J. P. Icenogle, S. Penaranda, B. Bankamp, K. Maher, M. H. Chen, S. Tong, A. Tamin, L. Lowe, M. Frace, J. L. DeRisi, Q. Chen, D. Wang, D. D. Erdman, T. C. Peret, C. Burns, T. G. Ksiazek, P. E. Rollin, A. Sanchez, S. Liffick, B. Holloway, J. Limor, K. MeCaustland, M. Olsen-Rasmussen, R. Fouchier, S. Gunther, A. D. Osterhaus, C. Drosten, M. A. Pallanseh, L. J. Anderson, and W. J. Bellini. 2003. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300:1394-1399.
43. Saif, L. J. 2004. Animal coronaviruses: what can they teach us about the severe acute respiratory syndrome? Rev. Sci. Technol. 23:643-660.
44. Sanchez, C. M., F. Gebauer, C. Sune, A. Mendez, J. Dopazo, and L. Enjuanes. 1992. Genetic evolution and tropism of transmissible gastroenteritis coronaviruses. Virology 190:92-105.
45. Simkins, R. A., P. A. Weilnau, J. Bias, and L. J. Saif. 1992. Antigenic variation among transmissible gastroenteritis virus (TGEV) and porcine respiratory coronavirus strains detected with monoclonal antibodies to the S protein of TGEV. Am. J. Vet. Res. 53:1253-1258.
46. So, L. K., A. C. Lau, L. Y. Yam, T. M. Cheung, E. Poon, R. W. Yung, and K. Y. Yuen. 2003. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet 361:1615-1617.
47. Talar-Williams, C., and M. C. Sneller. 1994. Complications of corticosteroid therapy. Eur. Arch. Oto-Rhino-Laryngol. 251:131-136.
48. Thacker, E., A. Summerfield, K. McCullough, A. Ezquerra, J. Dominguez, F. Alonso, J. Lunney, J. Sinkora, and K. Haverson. 2001. Summary of workshop findings for porcine myelomonocytic markers. Vet. Immunol. Immunopathol. 80:93-109.
49. VanCott, J. L., T. A. Brim, R. A. Simkins, and L. J. Saif. 1993. Isotype-specific antibody-secreting cells to transmissible gastroenteritis virus and porcine respiratory Coronavirus in gut- and bronchus-associated lymphoid tissues of suckling pigs. J. Immunol. 150:3990-4000.
50. Van Gucht, S., K. Atanasova, F. Barbe, E. Cox, M. Pensaert, and K. Van Reeth. 2006. Effect of porcine respiratory Coronavirus infection on lipopolysaccharide recognition proteins and haptoglobin levels in the lungs. Microbes Infect. 8:1492-1501.
51. Van Gucht, S., K. Van Reeth, and M. Pensaert. 2003. Interaction between porcine reproductive-respiratory syndrome virus and bacterial endotoxin in the lungs of pigs: potentiation of cytokine production and respiratory disease. J. Clin. Microbiol. 41:960-966.
52. Van Reeth, K., H. Nauwynck, and M. Pensaert. 1998. Bronchoalveolar interferon-alpha, tumor necrosis factor-alpha, interleukin-1, and inflammation during acute influenza in pigs: a possible model for humans? J. Infect. Dis. 177:1076-1079.
53. Van Reeth, K., H. Nauwynck, and M. Pensaert. 1996. Dual infections of feeder pigs with porcine reproductive and respiratory syndrome virus followed by porcine respiratory coronavirus or swine influenza virus: a clinical and virological study. Vet. Microbiol. 48:325-335.
54. Van Reeth, K., H. Nauwynck, and M. Pensaert. 2000. A potential role for tumour necrosis factor-alpha in synergy between porcine respiratory coronavirus and bacterial lipopolysaccharide in the induction of respiratory disease in pigs. J. Med. Microbiol. 49:613-620.
55. Van Reeth, K., and M. B. Pensaert. 1995. Production of interferon-alpha, tumor necrosis factor-alpha and interleukin-1 in the lungs of pigs infected with the porcine respiratory coronavirus, p.197-201. In Proceedings of the 3rd Congress of the European Society for Veterinary Virology, Interlaken, Switzerland.
56. Van Reeth, K., S. Van Gucht, and M. Pensaert. 2002. Correlations between lung proinflammatory cytokine levels, virus replication, and disease after swine influenza virus challenge of vaccination-immune pigs. Viral Immunol. 15:583-594.
57. Van Reeth, K., S. Van Gucht, and M. Pensaert. 2002. In vivo studies on cytokine involvement during acute viral respiratory disease of swine: troublesome but rewarding. Vet. Immunol. Immunopathol. 87:161-168.
58. Wang, H., Y. Ding, X. Li, L. Yang, W. Zhang, and W. Kang. 2003. Fatal aspergillosis in a patient with SARS who was treated with corticosteroids. N. Engl. J. Med. 349:507-508.
59. Wang, W., L. Ye, L. Ye, B. Li, B. Gao, Y. Zeng, L. Kong, X. Fang, H. Zheng, Z. Wu, and Y. She. 2007. Up-regulation of IL-6 and TNF-alpha induced by SARS-coronavirus spike protein in murine macrophages via NF-kappaB pathway. Virus Res. 128:1-8.
60. Ward, W. E., S. M. Donovan, and S. A. Atkinson. 1998. Dexamethasone-induced abnormalities in growth and bone metabolism in piglets are partially attenuated by growth hormone with no synergistic effect of insulin-like growth factor-I. Pediatr. Res. 44:215-221.
61. Weiler, H. A., Z. Wang, and S. A. Atkinson. 1995. Dexamethasone treatment impairs calcium regulation and reduces bone mineralization in infant pigs. Am. J. Clin. Nutr. 61:805-811.
62. Welch, S. K., and L. J. Saif. 1988. Monoclonal antibodies to a virulent strain of transmissible gastroenteritis virus: comparison of reactivity with virulent and attenuated virus. Arch. Virol. 101:221-235.
63. Wesley, R. D., R. D. Woods, and A. K. Cheung. 1991. Genetic analysis of porcine respiratory coronavirus, an attenuated variant of transmissible gastroenteritis virus. J. Virol. 65:3369-3373.
64. Wong, C. K., C. W. Lam, A. K. Wu, W. K. Ip, N. L. Lee, I. H. Chan, L. C. Lit, D. S. Hui, M. H. Chan, S. S. Chung, and J. J. Sung. 2004. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin. Exp. Immunol. 136:95-103.
65. Xu, D., Z. Zhang, L. Jin, F. Chu, Y. Mao, H. Wang, M. Liu, M. Wang, L. Zhang, G. F. Gao, and F. S. Wang. 2005. Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase. Eur. J. Clin. Microbiol. Infect. Dis. 24:165-171.
66. Yuan, L., L. A. Ward, B. I. Rosen, T. L. To, and L. J. Saif. 1996. Systematic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease. J. Virol. 70:3075-3083.